PATIENTS WITH ATRIAL FIBRILLATION AND CORNARY ARTERY DISEASE

Clinical trials for PATIENTS WITH ATRIAL FIBRILLATION AND CORNARY ARTERY DISEASE explained in plain language.

Never miss a new study

Get alerted when new PATIENTS WITH ATRIAL FIBRILLATION AND CORNARY ARTERY DISEASE trials appear

Sign up with your email to follow new studies for PATIENTS WITH ATRIAL FIBRILLATION AND CORNARY ARTERY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Which blood thinner is safer for heart patients? a Head-to-Head test

Disease control Recruiting now

This trial compares two blood thinners, edoxaban and apixaban, in people who have both atrial fibrillation (an irregular heartbeat) and coronary artery disease (narrowed heart arteries). Both drugs help prevent blood clots, but they are taken differently and may have different ri…

Matched conditions: PATIENTS WITH ATRIAL FIBRILLATION AND CORNARY ARTERY DISEASE

Phase: PHASE4 • Sponsor: Samsung Medical Center • Aim: Disease control

Last updated Aug 12, 2026 00:00 UTC

PATIENTS WITH ATRIAL FIBRILLATION AND CORNARY ARTERY DISEASE

Get alerted when new PATIENTS WITH ATRIAL FIBRILLATION AND CORNARY ARTERY DISEASE trials appear

Which blood thinner is safer for heart patients? a Head-to-Head test